Thermo Fisher Scientific Inc. (TMO) Stock Grade

About Thermo Fisher Scientific Inc.'s fundamentals

Thermo Fisher Scientific is a $217.9 billion healthcare company with a net profit margin of 15.1%, indicating it converts revenue into earnings at a solid rate. The company's revenue grew 3.9% year-over-year, which is modest growth for the sector, while its return on equity of 12.6% shows moderate efficiency in deploying shareholder capital. Trading at a P/E ratio of 32.3, the valuation reflects market expectations that are notably higher than many peers, and the company returns minimal capital to shareholders through dividends at a 0.3% yield.